Nurix Therapeutics, Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Drug Discovery Technologies
- ADMET
- Drug Discovery Technologies
Other Names/Subsidiaries
- DeCART Therapeutics
- Nurix, Inc.
Latest on Nurix Therapeutics, Inc.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Oak Hill Licenses Roche’s Rugonersen,
Gilead Sciences' acquisition of Leo Pharma’s signal transducer and activator of transcription 6 (STAT6) program is not just a major boost for the Danish group’s finances but also a nod to the growing
The pharmaceutical, biotech and other allied industries came together in London on 4 December to celebrate another year of exceptional achievement at the 20th Annual Scrip Awards at the Raffles hotel
NX-5948, Nurix Therapeutics’ treatment for relapsed or refractory chronic lymphocytic leukemia, and Ga68-PentixaFor, Pentixapharm’s radiodiagnostic for primary aldosteronism, are the latest investigat